Segmentation by type of preformulation service further refines the market taxonomy into four core offerings: Physicochemical characterization, Solubility assessment, Stability testing, and Compatibility studies. Physicochemical characterization, encompassing pKa, hygroscopicity, and polymorphism analysis, generates the largest share—estimated at 40 %—because it underpins all subsequent development steps across dosage forms. Solubility assessment follows with a 25 % share, reflecting the critical need to enhance bioavailability for both oral and parenteral candidates. Stability testing, which evaluates chemical and physical integrity under varied conditions, contributes roughly 22 % of market revenue, driven by regulatory mandates for shelf‑life data. Compatibility studies, covering excipient‑drug interactions, hold the remaining 13 %, essential for formulation optimization but applied more selectively. Together, these type‑based segments delineate the service portfolio that supports the broader application‑driven market, informing investment and capacity planning.